Those might not be a good direct comparison. Synribo isn't a TKI, it is quite possible those 60% and 18% achieving MCyR would not be the same patients. By the way, your 10.5 months mean time to MCyR for ponatinib can't be right because that implied slower.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.